Successful Systemic Thrombolysis in an Adolescent With Acute Ischemic Stroke

Neurologist. 2015 Sep;20(3):48-50. doi: 10.1097/NRL.0000000000000050.

Abstract

Introduction: Current treatment guidelines for acute ischemic stroke do not recommend thrombolytic therapy in children and adolescents as data are still very scarce.

Case report: We report the case of a 15-year-old boy who suddenly developed severe left-sided weakness and speech difficulty while stooling. Upon arrival at our Emergency Department, the National Institute of Health Stroke Scale (NIHSS) score was 18. Urgent neurovascular ultrasound showed a distal occlusion of the right internal carotid artery and occlusion at the origin of the middle cerebral artery (MCA) and the anterior cerebral artery. He was treated 2 hours after symptom onset with intravenous recombinant tissue plasminogen activator without any complication. At the end of thrombolysis, a complete recanalization was shown by transcranial Doppler sonography, although a brain magnetic resonance imaging disclosed an acute right middle cerebral artery stroke. At discharge, the boy had mild weakness on his left leg and slight left facial palsy: the NIHSS score was 2. To our knowledge, this is the first intravenous thrombolytic treatment ever reported in an adolescent in Italy.

Conclusions: Despite the lack of evidence regarding the safety and the efficacy of recombinant tissue plasminogen activator in pediatric stroke, this treatment option should be considered, especially in adolescents presenting within 3 hours from symptom onset in centers with consolidated experience in adult thrombolysis.

Publication types

  • Case Reports

MeSH terms

  • Administration, Intravenous
  • Adolescent
  • Brain Ischemia / prevention & control*
  • Carotid Artery Thrombosis / prevention & control*
  • Humans
  • Infarction, Anterior Cerebral Artery / prevention & control*
  • Infarction, Middle Cerebral Artery / prevention & control*
  • Male
  • Recombinant Proteins
  • Thrombolytic Therapy*
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / therapeutic use*
  • Treatment Outcome

Substances

  • Recombinant Proteins
  • Tissue Plasminogen Activator